SAN FRANCISCO – January 24, 2023 – Tivic Health® Systems, Inc. (“Tivic”) (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that Global Health & Pharma (GHP) has named Tivic Health the Most Pioneering Bioelectronic Medicine Company of 2022. “Thank you to the editors at GHP for again recognizing the […]
Tivic remains committed to ClearUP growth SAN FRANCISCO – December 9, 2022 – Tivic Health® Systems, Inc. (“Tivic”) (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that Tivic Health and Reliefband Technologies, LLC have, by mutual agreement, terminated the parties’ agreement for the acquisition of the Reliefband product line […]
Significant progress made to supply chain to support cost improvements and scaling SAN FRANCISCO – December 1, 2022 – Tivic Health® Systems, Inc. (“Tivic”) (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced it has hired ALOM Technologies Corporation (“ALOM”), a leader in global supply chain product and service delivery […]
65% growth in year-to-date revenue 146% increase in unit sales through direct-to-consumer channels for the same period Entered into definitive agreement to acquire Reliefband SAN FRANCISCO – November 14, 2022 – Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced its financial results for the quarter ended September […]
Agreement expected to reduce product manufacturing and shipping costs SAN FRANCISCO – November 10, 2022 – Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase health technology company focused on bioelectronic medicine, today announced it has entered into an agreement with Microart Services Inc., headquartered in Buffalo, New York, to manufacture, on a non-exclusive basis, certain components […]
Will Demo FDA-Approved ClearUP that Treats Sinus Pain and Congestion from Colds, Flu, and Allergies SAN FRANCISCO – November 7, 2022 – Tivic Health® Systems, Inc. (Nasdaq: TIVC) (“Tivic Health”), a commercial-phase health technology company focused on bioelectronic medicine, is bringing bioelectronic medicine to HLTH with ClearUP, an FDA-approved and clinically proven device that uses low-level […]
SAN FRANCISCO, CA – November 7, 2022 – Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that it will report financial results for the third quarter of 2022 via conference call and webcast on Monday, November 14, 2022, at 1:30 PM PT / 4:30 […]
Company Intends to Dramatically Expand Product Offerings into Bioelectronic Treatment of Nausea CEO to Host Investor Call/Webcast on Wednesday, October 19th at 1:30 PM PT / 4:30 PM ET SAN FRANCISCO – Tivic Health® Systems, Inc. (Nasdaq: TIVC) (“Tivic Health”), a commercial-phase health technology company focused on bioelectronic medicine, today announced it has entered into […]
SAN FRANCISCO, October 6, 2022 – Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that the company’s CEO will present at Fifth Bioelectronic Medicine Summit – Bioelectronic Medicine: Today’s Tools, Tomorrow’s Therapies organized by the Feinstein Institutes for Medical Research and the Columbia University School of Engineering. […]
SAN FRANCISCO, CA – August 30, 2022 – Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that the company’s CEO will present at the upcoming 148th National Investment Banking Association conference. WHO: Jennifer Ernst, Chief Executive Officer WHAT: The National Investment […]
